NasdaqCM - Nasdaq Real Time Price USD
Immix Biopharma, Inc. (IMMX)
2.3500
-0.0200
(-0.84%)
As of 2:43:23 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | -0.16 | -0.16 | -0.6 | -0.76 |
| Low Estimate | -0.16 | -0.16 | -0.62 | -0.87 |
| High Estimate | -0.16 | -0.16 | -0.57 | -0.65 |
| Year Ago EPS | -0.15 | -0.24 | -0.76 | -0.6 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.21 | -0.16 | -0.25 | -0.23 |
| EPS Actual | -0.15 | -0.24 | -0.15 | -0.15 |
| Difference | 0.06 | -0.08 | 0.1 | 0.08 |
| Surprise % | 28.57% | -50.00% | 40.00% | 34.78% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.16 | -0.16 | -0.6 | -0.76 |
| 7 Days Ago | -0.21 | -0.22 | -0.57 | -0.87 |
| 30 Days Ago | -0.21 | -0.22 | -0.68 | -0.89 |
| 60 Days Ago | -0.21 | -0.22 | -0.68 | -0.89 |
| 90 Days Ago | -0.21 | -0.22 | -0.73 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | 1 | 1 | 1 |
| Down Last 7 Days | 1 | 1 | -- | -- |
| Down Last 30 Days | 1 | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IMMX | -6.67% | 33.33% | 21.71% | -27.73% |
| S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/4/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/10/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/6/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/26/2024 |
Related Tickers
CVM CEL-SCI Corporation
2.5200
+7.30%
XLO Xilio Therapeutics, Inc.
0.7033
+0.47%
ACTU Actuate Therapeutics, Inc. Common stock
8.75
-2.34%
TRVI Trevi Therapeutics, Inc.
6.49
-8.14%
ENSC Ensysce Biosciences, Inc.
2.3600
-0.84%
QNCX Quince Therapeutics, Inc.
1.1800
+0.85%
KTTA Pasithea Therapeutics Corp.
0.9000
+1.60%
PYPD PolyPid Ltd.
3.4400
+5.20%
ANRO Alto Neuroscience, Inc.
2.5600
-0.39%
NUVB Nuvation Bio Inc.
2.4788
+0.15%